Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma — Papers | ScholarIQ

Scholar IQ

Help

Try ScholarIQ free

Upload Records Snowball Search Search OpenAlex

About the database

ScholarIQanswers from OpenAlex

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

PaperCitations, authors & open-access status

3,728

Citations

2,019

Year

bronze

OA Status

IDs:DOI OpenAlex

Related on ScholarIQ

Célèste Lebbé

Matteo S. Carlino

John B.A.G. Haanen

Iván Márquez‐Rodas